Minimal myocardial damage during coronary intervention is associated with impaired outcome

Abstract
Aims Studies on the glycoprotein IIb-IIIa receptor blocker abciximab in patients undergoing percutaneous coronary intervention consistently show a re

This publication has 0 references indexed in Scilit: